Fascinating discussion. Why is it one vs. another? Glucose is carried via the blood. Wouldn't it follow that a reduction in CBF would lead to a reduction in cerebral glucose availability? Perhaps bolstering Alan's position is the fact that E4 carriers, as early as our 2nd decade exhibit these changes. Would IR be present then? In modern Western society, I suspect the answer could be yes. It would be interesting to scan two groups of young E4 carriers; one a typical group of Americans, the other a group like us, hyper-focused on health. I suspect the latter wouldn't demonstrate a difference in either CBF or reduced glucose utilization... wild guess on my part.This is what work of Zlokovic and Ai-Ling Lin is all about. Saying these changes in cerebral blood flow as measured by glucose uptake on PET scans are due to cerebral insulin resistance is to interpret what is happening as 100% wrong.
That said, Reiman (2013) has clearly established the inverse correlation between peripheral hyperglycemia/IR and cerebral glucose utilization. In terms of translating this to our clinical strategies, we need to focus on increasing cerebral blood flow (exercise) and preventing IR to avoid AD. It's not an either/or.
Thank you, Susan & Theresa, for jumping in to remind us all to remain respectful when discussing and interpreting the science. There are many unknowns surrounding the APOE-ε4 gene. I appreciate having a safe place in which to translate the science into clinical strategies.